NIH-funded research R21 grant

Investigating how self-cleaving peptides function in different organisms

Official title: Self-cleaving peptides: Mechanisms and Use in Diverse Eukaryotic Species

Funded at University of Colorado Denver · NIH-10915707 · Data updated 2026-11-12

This study is looking at how a tiny germ called Giardia, which can make people sick, works differently than other germs, and by understanding this, researchers hope to find better ways to treat infections caused by Giardia.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionUniversity of Colorado Denver
NIH-funded
Lab location1 site (Aurora, UNITED STATES)
Project startSeptember 1, 2023
Project endAugust 31, 2025
Funding year2024
Award (this year)$230,342
NIH project number5R21AI167423-02
Project IDNIH-10915707 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals infected with Giardia lamblia or those at risk of such infections.

Less likely to help

Patients with infections caused by other pathogens unrelated to Giardia lamblia may not benefit from this research.

What this research studies

This research focuses on Giardia lamblia, a single-celled organism that causes infections in millions of people. The study aims to understand how self-cleaving peptides, which are crucial for viral replication, behave differently in Giardia compared to other eukaryotes. By examining the structure of Giardia's ribosomes, the researchers hope to uncover fundamental differences that could lead to new insights into biological processes and potential treatments. Patients may benefit from this research as it could lead to better understanding and treatment of infections caused by Giardia.

Why it matters

Potential benefit: If successful, this research could provide new insights into treating infections caused by Giardia lamblia and similar pathogens.

How similar studies have gone: While the specific approach of studying 2A peptides in Giardia is novel, similar research has shown that understanding ribosomal mechanisms can lead to significant advancements in treating viral infections.

Where this research is happening

  • University of Colorado Denver
    Aurora, United States
    Active

Researchers

  • Principal investigator: Rissland, Olivia Selfridge — University of Colorado Denver
  • Study coordinator: Rissland, Olivia Selfridge

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.